Arcosa, Inc. (ACA) — Fair Value Analysis
Base-case fair value (P50): $115.37 · Current price: $124.14 · Verdict: Fairly Valued
The Verdict on ACA
Based on our Monte Carlo simulations, ARCOSA INC (ACA) is currently assessed as Fairly Valued. While ACA's stock trades at $124.14, its median fair value (P50) is calculated at $115.37. This indicates an -7.1% difference from its current market price. The comprehensive analysis across thousands of forward-looking scenarios suggests that ACA's current valuation aligns closely with its intrinsic worth, neither presenting a significant discount nor a premium that would warrant an "undervalued" or "overvalued" verdict based on the Monte Carlo output.
How ACA stacks up against Industrials
Within the Industrials sector, ARCOSA INC (ACA) currently holds a weak quality tier. This assessment reflects the company's operational and financial health when benchmarked against its industry peers. While the weak quality tier doesn't directly dictate an overvalued or undervalued status, it is an important qualitative factor underpinning the Monte Carlo simulations that lead to ACA being deemed Fairly Valued. Investors should weigh this quality ranking against the computed median fair value of $115.37 when considering ACA's prospects compared to the market price of $124.14.
What this means for investors
For investors tracking ARCOSA INC (ACA), the current assessment of Fairly Valued suggests that the market price of $124.14 accurately reflects the company's present financial and operational outlook, as captured by our simulations. The slight -7.1% gap between the current price and the $115.37 median fair value reinforces this neutral stance. Considering ACA's weak quality tier within the Industrials sector, this fair valuation implies that growth catalysts or significant operational improvements would be required to drive substantial upside beyond the calculated $115.37. Sign up for a free FairCurve account to see the full bear and bull distribution and track ACA's fair value as new fundamentals are released.
Frequently Asked Questions
Is ACA overvalued or undervalued right now?
Based on Monte Carlo simulations, ACA's median fair value (P50) is $115.37, which is -7.1% compared to its current price of $124.14, indicating it is currently Fairly Valued.
What is the bear case and bull case for ACA?
The full Monte Carlo distribution, including bear (P10) and bull (P90) targets, along with the probability of upside, is available when you sign up for a free FairCurve account.
How does FairCurve calculate ACA's fair value?
FairCurve calculates ACA's fair value using Monte Carlo simulations, running thousands of forward scenarios to determine a probabilistic range of outcomes and a median (P50) fair value.
How can I track ACA's fair value as it changes?
Add ACA to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings reports or significant fundamental data are released.